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Abstract: While the promise of wearable sensor technology to transform physical rehabilitation has
been around for a number of years, the reality is that wearable sensor technology for the measurement
of human movement has remained largely confined to rehabilitation research labs with limited
ventures into clinical practice. The purposes of this paper are to: (1) discuss the major barriers in
clinical practice and available wearable sensing technology; (2) propose benchmarks for wearable
device systems that would make it feasible to implement them in clinical practice across the world
and (3) evaluate a current wearable device system against the benchmarks as an example. If we can
overcome the barriers and achieve the benchmarks collectively, the field of rehabilitation will move
forward towards better movement interventions that produce improved function not just in the clinic
or lab, but out in peoples’ homes and communities.
Keywords: rehabilitation; motor function; wearable sensors; outcomes; measurement; implementation
1. Introduction
Wearable sensor technology to measure human movement is rapidly evolving. Motion-sensing
wearable devices continue to get smaller, lighter and have more data storage space, with even better
products anticipated in the future. These wearable devices are ubiquitous in the general public in
the form of a variety of commercially available, consumer-grade products. Here, we use the term
‘device’ to refer to the wearable unit, ‘sensor’ to refer to the sensors within the device, and ‘wearable
device system’ to refer to the collective hardware and software package (see Box 1 for other operational
definitions used in this paper). This paper intentionally excludes cell phones as a wearable because cell
phones are used for a multitude of purposes and are not routinely ‘worn’ in the same location within
and across people. Because of the focus on movement, this paper also excludes wearable sensors
designed to measure physiological signals such as heart rate, oxygen saturation, and respiratory rate.
Wearable devices include one or more specific sensors, with accelerometers being the most common
sensor for quantifying human movement. Many devices also include magnometers, inclinometers,
gyroscopes, and light sensors.
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Box 1. Operational Definitions.
Commercially-available: device systems that can be purchased through companies or organizations.
Laboratory-available: device systems developed in one or more labs and not available for purchase by the
general public.
Consumer-grade: device systems that are marketed directly to consumers, intended to be used by anyone.
Research-grade: device systems that are marketed to researchers and healthcare professionals, intended for
use to be managed by someone with specialized training.
Activity: Execution of a task or action, such as walking, dressing, or bathing [1].
Capacity: Activity that is assessed in a structured setting, usually with a standardized tool, such as the 10 m
walk test or the Box and Block test. Alternate terms are function and functional capacity [1].
Performance: Activity that is assessed in an unstructured, free living setting. Performance can be measured
directly via wearable devices, or via self-report with questionnaires [1].
The potential benefit of wearable sensor technology for physical rehabilitation has been discussed
in the literature since the early 2000s [2]. The real promise for rehabilitation is that wearable device
systems can measure human movement in real world settings, not just in the structured environment
of the clinic or laboratory. People seek physical rehabilitation services to improve their movement in
daily life, so rehabilitation professionals need a way to quantify that movement in order to best help
their patients. In the published literature to date, two overlapping scientific cohorts are responsible for
the majority of the progress with wearable sensor technology. The first cohort includes the engineering
groups, who are developing and testing sensors, software, and algorithms. The second cohort includes
clinician scientists who are validating sensor-derived metrics in clinical populations and deploying
these metrics to answer questions and measure outcomes in rehabilitation studies. While wearable
device systems to measure human movement have become more commonplace in research studies,
they have not yet been widely implemented in routine clinical practice [3]. Multiple barriers arising
both from clinical rehabilitation practice and from the current state of commercially-available devices
need to be overcome before there is widespread adoption into routine care. We note that these barriers
and their relative importance may vary somewhat around the globe.
The purposes of this paper are to: (1) discuss the major barriers in clinical practice and available
wearable sensing technology; (2) propose benchmarks for wearable device systems that would make it
feasible to implement them into clinical practice across the world; and (3) evaluate a current wearable
device system against the benchmarks as an example. This field is in its early stages. The evolution
of the telephone is a good analogy for our field. Early telephones look and function nothing like the
sleek, smart phones we use today, with advancements in telephone technology spread out over more
than 100 years. This paper is intended as a small step, specifically focused on helping the collective
advancement of wearable sensor technology from research groups into routine clinical practice.
Our larger goal is to move the field of physical rehabilitation forward towards better interventions that
produce improved movement performance in homes and communities, not just improved capacity in
our clinics and labs.
2. The Current Situation in Clinical Care
There are multiple factors influencing physical rehabilitation that may impact the implementation
of wearable device systems into routine clinical rehabilitation practice. Many influencing factors are
generic, i.e. they influence any type of change in clinical practice. This paper intentionally focuses on
two key factors most strongly influencing clinical uptake of wearable sensor technology. These key
factors are the time constraints present in everyday clinical practice and the salience of information from
wearable device systems by physical rehabilitation professionals. Note that medical- or research-grade
devices that are deployed into clinical care must meet all the clinical standards, defined by the
International Organization of Standards (ISO/TC 173 for Assistive Products and ISO 10667-1:2011 for
Assessment Service Delivery), and evaluated by regulatory agencies. Regulatory approval is a long,
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challenging process, varying somewhat by geographic location; a discussion of this process is outside
the scope of this review.
2.1. Busy Clinical Practice Affords Little Time for Anything Else
Across the world, patients are seen in a variety of rehabilitation settings including acute and
long-term hospitals, specialized facilities (skilled nursing, inpatient or acute rehabilitation), outpatient
clinics, virtual visits, or at home, each with different requirements for productivity. In the United States
for example, productivity standards for physical therapists can be upwards of 85% with reimbursement
only for billable units [4]. This means that therapists are working under the expectation that upwards
of 6 h 48 min of their 8-h workday are devoted to direct patient care, with patients scheduled back to
back and little or no time in between. Meeting these standards can be challenging as direct patient
care time is often limited by the patients themselves, both within the hospital or inpatient setting
and outside the hospitals in outpatient, ambulatory care settings. Common disruptions to direct
patient care time in the inpatient setting are delays or interruptions due to hygiene or dietary concerns,
and conflicting medical needs. Similar disruptions in the outpatient setting most frequently arise from
transportation delays. Figure 1 provides two examples of typical rehabilitation sessions (Figure 1A:
inpatient, physical therapy, Figure 1B: outpatient occupational therapy) to illustrate how planned,
scheduled direct patient care time does not often equate to actual care time [5,6].
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Figure 1. Clinicians encounter many barriers to spending time in direct patient care. Examples of inpatient
physical therapy (PT) 1 h session (A) and outpatient occupational therapy (OT) 45 min session (B).
In addition, regardless of the clinical setting or geographic location, physical rehabilitation
professionals (physicians, physical and occupational therapists, etc.) in today’s busy clinical environment
have many competing priorities above and beyond direct patient care that limit available time [3,7–9].
Rehabilitation clinicians have administrative demands related to documentation, addressing patient and
family concerns, and coordination of care with other healthcare team members [10,11]. Competing demands
on time are often balanced by the rehabilitation professional multi-tasking, providing group treatments
(allowable in some settings or countries, but not allowable in others), and completing administrative tasks
while providing treatment during a session. Collectively, these pressures limit time and energy to trial
new technology, including wearable device systems.
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Figure 2A shows an example of current time costs for using a wearable sensor system within
clinical practice, with time estimates based on our laboratory protocol [12]. Asking rehabilitation
professionals to charge, program, don/doff, process, and share results (both with the patient and
other health professionals through an electronic medical record) of wearable device systems is
unrealistic if it cannot be completed quickly during a patient treatment session. Figure 2B shows a
clinically-feasible time cost that would foster implementation of wearable device systems into routine
clinical rehabilitation practice.
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Figure 2. Time Cost for Clinical Implementation of earable Device Systems. A: Current time cost in
clinical practice. B: Estimated time cost for realistic implementation into clinical practice. The first two
boxes in A & B are estimates for an experienced clinician using a wearable device system with a new
patient. Red boxes indicate non-billable time while green boxes indicate billable time. EMR: electronic
medical record. * Wear time may vary from hours to several days.
The above examples are drawn from the healthcare system in the United States. While other
countries might not currently face such severe time constraints, all counties face at least some.
Additional challenges faced across multiple continents include under-sourced physical rehabilitation
services (i.e. a limited number of professionals available), which may lead to self-imposed pressures
for professionals to treat as many people as quickly as possible. Regardless of the unique situations in
each country, it is unlikely that these time constraints and competing priorities are going to change
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in the foreseeable future. For wearable device systems to be widely implemented into rehabilitation
care around the globe, the technology needs to fit in seamlessly, minimizing disruption to busy,
clinical settings.
2.2. Clinicians Are Still Building towards Understanding the Added Value of Wearable Sensor Data for Clinical
Rehabilitation Practice
The World Health Organization’s International Classification of Function, Disability, and Health
(WHO-ICF) describes three levels of classification for any health condition (disorder or disease),
including body function and structure, activity, and participation [1]. Activity is considered the ability
to execute tasks or actions and can be subdivided into the capacity for activity, i.e. what a person can
do in a structured environment, and performance of activity in daily life, i.e. what a person actually
does (see Box 1). Established in the field of physical rehabilitation is the importance of standardized
outcome assessments to evaluate change over the course of clinical care [13]. Recommended activity
level measures included in rehabilitation clinical practice guidelines around the world nearly always
assess capacity, not performance [14]. But as mentioned in the Introduction, individuals who engage
in physical rehabilitation services typically seek improvement in movement performance within their
daily lives [15]. Assessing the impact of rehabilitation interventions in the context of an individual’s
life could, therefore, serve as a primary indicator of effectiveness of rehabilitation interventions.
Examples of using performance-level tracking in physical rehabilitation are the use of a single wearable
sensor worn at the ankle to track daily walking (e.g., steps/day), or the use of two wearable sensors worn
on the left and right wrists to track upper limb activity (e.g., use ratio, which is the relative duration of
activity in one limb vs. the other). Objective, performance-level tracking via wearable devices across
clinical episodes of care for decision-making, however, is an emerging, yet not established practice.
While there is promise for the adoption of performance-level tracking within clinical populations,
several clinical assumptions stand in the way of wide-spread adoption. First, there is the widespread
assumption that capacity measures taken in the clinic reflect performance measures in daily life.
Capacity is a snapshot of ability at a singular time point in a structured environment, whereas
performance measures capture real-world activity that includes the ecological validity of an individual’s
free-living condition. Published data on gait speed, an index of walking capacity, and steps per day,
an index of walking performance, illustrate this problem. Gait speed, measured in the clinic, generally
accounted for 30–45% of the variance in steps/day, leaving up to 70% of the variance in daily stepping
unexplained [16,17]. For example, individuals in a recent study with self-selected gait speeds around
0.8 m/s ranged from about 750 steps/day to over 6000 steps/day (see Figure 2B of [18]). Without a direct
measure such as those provided by wearable device systems, a clinician has limited insight about
walking or other movement performance in daily life. Up to the present time, physical rehabilitation
clinicians have had to rely primarily on self-report measures to quantify the amount, frequency and
duration of movement outside of clinical services. Unfortunately, self-report measures have been
shown to lack consistency with more direct assessments [19,20]. Thus, wide-spread adoption of
wearable device systems into routine clinical rehabilitation practice will provide new, important
information for clinical management.
The second clinical assumption is that a change in an individual’s capacity is equivalent to a
change in that individual performance in daily life. Over the past few years, multiple reports have
now demonstrated discrepant outcomes in capacity and performance over the course of research and
clinical interventions [21–24]. Each of these aforementioned belief barriers will require educational
strategies tailored towards rehabilitation professionals to improve adoption of performance tracking
with wearable device systems within clinical populations.
The great news is that emerging data exist demonstrating the utility of performance-level tracking
at improving a variety of outcomes and monitoring the effects of disease processes on movement
longitudinally [25,26]. Performance monitoring as part of research interventions has been effective at
increasing daily stepping, improving daily physical activity, and reducing sedentary time in healthy
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populations (see [27] for review). In clinical populations, performance tracking has been effective at
improving functional outcomes including walking endurance [28,29] and daily walking activity [30,31]
in the lower limb, and has proven to be sensitive to changes in real-world upper limb use across both
research and clinical interventions [22,32]. Further, tracking has also been sensitive to the degradation
of movement in daily life in both static [33] and progressive [34] disease processes. Advantages of
having performance-level measurements from electronic, internet-connected wearable device systems
include: (1) the storage of data in secure, remote databases; (2) the ability to analyze these measurements
across large data sets; and the subsequent ability to recommend specific actions based on the results of
these measurements. Increased adoption of performance monitoring in the clinical environment could
provide the big data required to elucidate the full potential of wearable sensing technology.
3. The Current Situation with Wearable Device Systems
3.1. Commerically-Available, Consumer-Grade Device Algorithms Have Limited Accuracy in Disabled Patient
Populations
A major barrier for widespread clinical adoption of wearable sensor technology is that the most
accessible wearable device systems, those marketed directly to consumers, have questionable accuracy
in rehabilitation populations. Using terminology set out in the V3 framework [35], the problem is
not in the verification of the sensor itself, but rather lies in the analytic and clinical validation of
the algorithm. People seeking rehabilitation services often do not move normally, such that the
algorithms programmed into consumer-grade devices are inaccurate in identifying or quantifying their
movement [36–41]. Continuing with our mainstream metric of walking performance, steps/day has
been evaluated across many consumer-grade devices. Studies have evaluated the accuracy of these
devices across a variety of functional activities and environmental settings, at different placements
on the body, and across a wide range of abilities. There was wide variability in the accuracy of
these devices in individuals with normal gait speed [42,43]. Furthermore, in individuals who utilize
assistive devices (e.g., cane, walker) [44–46], walk with slower speeds (e.g., < 0.8 m/s) [36–41], or have
interruptions in continuous walking [47,48], even higher levels of inaccuracy have been identified.
The Fit-Bit Ultra (Fitbit Inc., San Francisco, CA, USA) consumer-level device, for example, has been
shown to systematically under-estimate steps for individuals with a diagnosis of stroke and traumatic
brain injury over a 2-min walk test, with greater inaccuracy for those who took less steps per minute
and those that walked ≤ 0.58 m/s [41]. As many individuals who seek physical rehabilitation walk
at slower speeds, this poses a major barrier for accurate, objective monitoring. In contrast to the
consumer-grade devices, commercially-available, research-grade sensors such as the Step Activity
Monitor (Modus Inc., Edmonds, WA, USA) have demonstrated strong reliability and accuracy across
varied levels of abilities, including differing medical diagnosis, variable gait speeds, and use of assistive
devices [41,49–54] with limited data across differing environmental conditions [40,54–56]. Though this
research grade device is accurate and reliable in individuals with physical impairments, the device
may lack key features that would be essential for widespread clinical adoption (see Section 4 below).
Unfortunately, this discussion is an example of only one variable derived from a wearable device.
When additional variables are examined, the depth of work to integrate these devices into clinical
practice grows exponentially.
3.2. Research-Grade Device Systems Are Expensive and Not yet Clinician- and Patient-Friendly
Most research-grade devices work in conjunction with software systems that require a separate
computer program to set-up, download and examine the data. To be feasible in the clinic,
every rehabilitation professional would need the necessary computer program loaded onto their
laptop or other computer they use for clinical care, which would be expensive. In addition, cost of
devices for multiple patients and multiple limbs (e.g., wear one device on each wrist to measure
upper limb performance) could quickly make wearable sensor technology unreachable for most clinics.
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Beyond the cost, current output from research-grade wearable device systems is not easily accessible in
a timely manner for rehabilitation professionals or for their patients. Current research-grade systems
require training to use. Training involves both how to use the device (e.g., turning on/off, charging,
specific requirements for sensor placement wear) and how to use the system (e.g., programming the
device, uploading/storing data, translating device output into clinically relevant values). For wearable
device systems with proprietary software algorithms, only the default outputs (or variables) are
available. If the clinician needs variables beyond the defaults, they would need a research colleague
to write code and extract them. Research-grade system outputs (default or otherwise, see Table 1
for variables summary) are difficult to provide quickly during or outside of a treatment session.
Furthermore, if the rehabilitation clinician has taken the effort to extract the data and variables,
the output is not yet patient-friendly. Researchers have tried to bridge this gap by transforming
outputs into patient-friendly graphs, but the process is cumbersome and has not yet yielded improved
results [57]. For the clinically-important information derived from the sensors to be widely utilized by
patients and clinicians, wearable device systems will likely need to be less expensive, continuously
streamed [58], and on an accessible consumer-based platform [9]. Wearable device systems will
need to be compatible with and seamlessly integrated into the electronic medical record to be readily
adopted [59] and to contribute to the quality and effectiveness of rehabilitation services.
3.3. Standardization of Output Variables in Research Is Limited to Date, with Much Work to Do
The pathway to routine clinical rehabilitation implementation for wearable sensor technology
is not just impeded by current clinical care and available devices, but also by the state of the science
about the output variables. While it is clear that measurement of outcomes is essential in both research
and clinical practice, the pathway to an established outcome measure or sensor-based variable is a
long, hard one [60,61]. It is critical that measures and variables are thoroughly vetted, since scores
obtained may be used to make diagnostic and rehabilitation management decisions. Prior to any
measure being routinely implemented into clinical rehabilitation care, multiple studies evaluating
the psychometric properties and clinical utility of the measure are necessary [60–63]. Beyond the
verification of sensor signals [35], variables must first demonstrate reliability, or consistency of results
obtained, indicating that one can trust that the obtained value is stable. Validity is the second hurdle,
with multiple layers of validity. These layers, in hierarchical order, include: (1) face validity (does the
variable appear to capture the underlying construct); (2) content validity (does the variable adequately
capture/sample the underlying construct); (3) criterion-related validity (how does the variable agree
with other measures or the gold-standard measure of the same construct); and (4) construct validity
(how well does the variable measure the construct). If a sensor-based variable were to be used to make
diagnostic decisions, discriminitive validity (how does the variable distinguish between those with
and without a specific condition) and predictive validity (how well does the variable predict future
outcome) would also need to be demonstrated in the population of interest. Responsiveness is the
third and final hurdle and includes the ability of the variable to capture the range of the construct and
its sensitivity to change over time.
Table 1 is a sample list of variables proposed in the literature to measure important rehabilitation
constructs that might be used for diagnostic or clinical decision-making. These variables have largely
been derived from data captured on research-grade devices and calculated with custom software
developed in laboratories. The variables are intended to capture different movement constructs
that may be of interest to physical rehabilitation clinicians. We have excluded most measures of
general physical activity (e.g., caloric expenditure), except steps/day, since general physical activity
measures are an extensive topic in their own right. Variables are presented based on their intention to
quantify movement at either the lower (generally captured via one sensor on one leg) or upper limb
(generally captured with one sensor on each arm). Based on the available data, variables are marked
as to their exploratory status and how quality and quantity of data are related to reliability, validity,
and responsiveness.
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Table 1. A sample of wearable-derived variables proposed in the literature. This list is not exhaustive,
with new variables proposed all the time. Published variable data have been judged as: Green = sufficient
data for implementation into clinical practice; Yellow = some data available to-date, but not yet sufficient
for implementation; and Red = no data yet.
Variable Name
Explored In: Evaluation in Health Condition:
Absence of Health
Condition
Health
Condition Reliability Validity Responsiveness
Lower Limb [16,18,21,30,34,40,41,49,53,57,64–70]
Time-based variables
% time inactive • • • • •
Walking duration • • • • •
Amount-based variables
Steps/day • • • • •
Bouts/day • • • • •
Steps/bout • • • • •
Intensity-based variables
Stepping intensity • • • • •
Maximum output • • • • •
Mod. intensity minutes • • • • •
Peak activity index • • • • •
Other variables
Step length variability • • • • •
Upper Limb [21,32,71–96]
Time-based variables
Hours/duration of use • • • • •
Use/activity ratio • • • • •
Amount-based variables
Acceleration area • • • • •
Activity counts • • • • •
Mono-arm use index • • • • •
Intensity-based variables
Acceleration variability • • • • •
Acceleration magnitude • • • • •
Acceleration asymmetry • • • • •
Laterality index • • • • •
Magnitude ratio • • • • •
Bilateral magnitude • • • • •
Other variables
Variation ratio • • • • •
Jerk asymmetry • • • • •
Spectral arc length • • • • •
There are three key points to take away from this table. First in looking at the left-hand column,
there are many variables with different names and often different formulae that may be capturing
similar or related constructs of movement. This is both good and bad. Similarity is good because it
signifies that the movement construct is considered important by multiple groups. Different names
and different formulae are bad for future progress because they make comparisons across studies,
samples, and populations difficult. Second in looking at the next two columns, exploratory data are
available for many variables. This highlights the creativity that will be needed to really understand
movement constructs, variables, and relationships with clinical practice. Third and most importantly
in looking at the right-hand columns, there is a tremendous amount of work needed for most of these
variables to demonstrate the reliability, validity, and responsiveness necessary for adoption into routine
rehabilitation clinical practice. Only one variable, steps/day has sufficient established psychometric
and clinical utility to make it worthy of recommendation to clinicians, i.e. evidence of strong, stable
psychometric properties across multiple studies with large samples. Another variable, the use ratio for
the upper limb, is making good progress towards this goal, after its initial proposal some 20 years
ago [81]. Since many of the other variables are only recently proposed, it may be a long time before
needed data are available. We are hopeful that once one or a few variables are deployed into routine
care, the process for deploying other variables may be accelerated.
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To achieve standardization of variables derived from wearable devices, our field will need to
communicate and collaborate on issues such as: (1) sensor placement on the limbs; (2) filtering
algorithms for raw data; and (3) sensor-independent reporting of variables (e.g., gravitational units and
not activity counts, which vary by manufacturer). Comparisons across studies are often impossible due
to these issues [97]. For example, it is unfortunately not possible to compare upper limb activity levels
in a small sample of children with Duchene Muscular Dystrophy [98] to a larger, referent sample of
typically developing children [83]. The two studies evaluated conceptually-similar variables, but used
different calculations, different sensors, and different filtering algorithms. Going forward, it would be
of great benefit to develop open-access databases for normative or referent data, in order to compare
those with and without specific health conditions. Further progress might be made by pooling or
sharing currently available datasets for meta-analyses.
3.4. Different Clinical Populations Will Need Different Metrics for Clinical Decision-Making
Much of the variable development summarized above has occurred in the stroke rehabilitation
population. While individuals with stroke represent a substantial portion of the world-wide physical
rehabilitation population, there are many other clinical populations that could benefit from the ability to
capture motor performance in daily life. Given the heterogeneity of physical rehabilitation populations,
it is highly likely that different clinical populations will need different wearable-derived variables
for clinical decision-making [99]. Important sensor variables developed for one population may not
be clinically relevant for another population. For example, the use ratio is an upper limb variable
reflecting the relative time one limb is active compared to the other [81,100]. The use ratio has clear
clinical relevance in rehabilitation populations with asymmetric effects on the limbs, such as stroke,
hemiparetic cerebral palsy, limb amputation/prosthetic use, and recovery from unilateral upper limb
surgery. It has little clinical relevance, however, for those with very mild or no asymmetries in motor
abilities, such as children with Duchene’s Muscular Dystrophy or hyperactivity disorders, or for adults
with some brain injuries, and many spinal cord injuries. The ultimate goal of any clinical assessment,
including variables derived from wearable devices is that a value or score on the variable informs
clinical-decision making, such that without this value or score, a different clincial decision would have
been made and a worse outcome might have occurred. Thus, our challenge going forward extends
beyond establishing reliability, validity, and responsiveness for wearable-derived variables towards
demonstration of how the score or value can change clinical practice.
3.5. Special Considerations for Complexity in Some Populations
3.5.1. Children
Wearable device systems can be a powerful assessment tool for children as objective assessment
of their motor activity is difficult. Direct behavioral observation can be used to objectively assess
children in their typical environments but that is costly, time-consuming, and only feasible in research.
Clinic-based assessments are time consuming, require trained experts, have subjective components,
and require the children to be assessed outside of their familiar environment. Furthermore, children
under 10 or children with special needs cannot always follow commands or accurately report on
their performance [101]. Proxy-reports from parents or teachers have limited accuracy [101,102].
Wearable devices, therefore, can provide pediatric rehabilitation clinicians with real-world, objective
performance data on their patients [103–106]. Wearable devices have been used to research the behavior
of children with attention deficit-hyperactivity disorder (ADHD) in the classroom [107]. In autism
spectrum disorder research, wearable devices have been used to study sleep patterns, stereotyped
behaviors, and metabolic disease risk [108–114]. Researchers have also used wearables to identify
infants with developmental delays and infants with movement disorders associated with cerebral
palsy [115,116] and children with ADHD [105]. While their value for pediatric physical rehabilitation
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is clear, two special considerations for pediatric wearable device system use are the data collection
protocol and the physical design of the device.
Particularly in pediatric studies, there has been wide variation in data collection procedures with
respect to device placement and wearing duration. Devices are placed on the waist, ankle, one or both
wrists, or a combination of these sites. The issue of device placement is further complicated by the
different, and often more intense, movement activity in children (e.g., swinging, climbing, and sliding
on playgrounds) compared to adults. While multiple sensors can quantify movement in ways a single
sensor cannot, multiple sensors create a greater burden for the wearer, particularly on infants and
small children. Implementation of wearable sensor technology into pediatric clinical practice will
require thoroughly vetted protocols that can maximize sensor information and minimize the number of
sensors and duration of wear. Thoroughly vetted protocols will also be an important part of convincing
parents to allow and promote device wearing in their children.
Routine clinical implementation of wearable devices and systems for pediatric rehabilitation
populations will also depend on the physical design of the device and how it is secured to the
individual. Size, weight, aesthetics, and ease of donning/doffing, are all key considerations. An ideal
wearable device for pediatric patients would be small and light enough for infant wrists and ankles but
robust enough to handle the stresses encountered while being worn by a child or teen for prolonged
periods. The device must not impede or alter the movements that are being recorded [117]. The strap
should be strong, non-absorbent, easy to remove and clean. For young children, playful or colorful
aesthetics may increase compliance [118]. Simple hook-and-loop or buckle closures make donning and
doffing devices easy for caregivers. Some pediatric populations will have sensory sensitivities and,
for them, strapping that is soft and compliant but secure needs to be available. Devices are ideally
waterproof, which can prevent recording interruptions during hand washing or bathing, and data
capture can continue during swimming or other water-based activities. If these special considerations
to implementation are overcome, wearable device systems can bring uniquely powerful diagnostic
and prognostic information into pediatric care, a setting where real-world, objective assessment is
otherwise very difficult.
3.5.2. Individuals with Cognitive Deficits
Great potential exists for the use of wearable devices in the routine clinical care of individuals
with cognitive impairment. For example, ankle-mounted accelerometers have been used to distinguish
between healthy controls and participants with Alzheimer’s disease prior to the onset of major
clinical behavioral impairments [119]. Cognitively impaired individuals cannot always accurately
report on their performance in daily life and proxy-reports from caregivers may lack accuracy [120].
Wearable devices can avoid these issues by providing clinicians with objective, real-world data.
Several special considerations arise from the individual’s cognitive impairment. Those individuals
with more severe impairment may not understand the purpose of a wearable device. Devices that
are small, light, and comfortable are more unobtrusive and will help avoid resistance to wear [3].
Device discomfort has led to as much as 25% withdrawal from studies of a neurological population [121].
The level of caregiver support available will be critical for success, as individuals with severe impairment
may not be able to communicate discomfort (e.g., excess tightness, skin irritation) during device
use. Device design could facilitate comfortable wearing by employing soft but strong materials and
avoiding hard edges near areas of fragile skin. There will be a trade-off between the simplicity to don
and doff by the patient themselves [3,121] versus minimizing the proclivity to remove the devices
when it is not appropriate to do so. An option of a more secure clasp that requires caregivers or
clinicians to remove may be appropriate. When possible, wearable devices will need to be attached to
the patient and not their clothing, to avoid inadvertently laundering or discarding the device [121].
Wearable devices with long battery life could remove the need for cognitively-impaired individuals
and/or caregivers to remember to monitor and charge the battery. Devices that are aesthetically
pleasing may facilitate compliance [3], such as the emerging devices designed to appear as watches or
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jewelry (e.g., Motionlogger Micro Watch, AMI, Ardsley, NY, USA; Motiv Ring, Motiv, San Francisco,
CA, USA). Lastly, cognitive impairment heightens the need for clear caregiver education related to
the device protocol and interpretation of results, preferably with simple graphical instructions and
data visualizations.
4. Benchmarks for Future Development
4.1. Proposed Benchmarks
While there are serious barriers to implementation of wearable device systems into routine
physical rehabilitation practice, there is also substantial opportunity for growth and development
in the nascent wearable sensor technology field. Here, we propose benchmarks for wearable device
systems that might be readily adopted into clinical practice. Figure 3 is a visual illustration of the
barriers and benchmarks. Each barrier is represented by a circle, with barriers that will be more difficult
to overcome indicated by larger circles and hotter colors. Once barriers are overcome (circles shrink
enough to fit through the funnel), then wide-spread clinical implementation (green rectangle) will be
possible. The specific benchmarks (Table 2) are intended to serve as a guide for engineers, software
developers, clinician-scientists, and clinicians alike as we pursue this important goal. They arise from
the 10+ year history of using wearable device systems in our laboratory with more than 400 research
participants, our clinical practice experience, and discussions with a range of rehabilitation clinicians.
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Table 2. Benchmarks for wearable device systems that will facilitate implementation into routine
physical rehabilitation clinical practice.
Benchmark
Convenience for purchase and use Commercially-available, consumer-grade device system that can be easily usedby clinicians and consumers; comprehensive, accessible tech support.
Initial set-up time for clinician 5–6 min for first time with new patient.
Routine set-up time for clinician ≤1 min in subsequent times with same patient.
Time to extract data and generate output or report ≤5 min
Ease of donning/doffing for patient ≤2 min; without assistance from another person if intended for home use.
Comfort for extended wear
Soft plastic or other flexible strapping that can be tolerated 12–24 h/day; no hard
edges on device that push into skin; water resistant so does not have to be
removed for bathing, dishwashing, etc.
Device operations ≥95% of the time, device collects, stores, and/or uploads data as programmedand does not malfunction.
Algorithms for extracting data and generating
variables of interest
≥90% accuracy to measure intended construct; must be accurate across a broad
range of movement abilities typically seen in physical rehabilitation clinics.
Standardization of variables of interest
Reliability: consistently captures construct with reliability coefficients of ≥0.80.
Validity: comprehensively captures construct that has known relevance to
clinical decision-making and management.
Responsiveness: detects changes of ≥5%; changes of 5–10% or higher provide
relevant information for clinical decision-making and management.
Values can be computed & reported in sensor-independent units.
Report to clinician and patient
Consumer friendly, targeting audience with ≤ secondary school education; 1–3
key outcome variables presented; simple graphics with colors to make
accessible across languages and language and/or cognitive deficits; ability to
integrate into electronic medical record.
As with any technology, wearable device systems that are commercially-available with
comprehensive, accessible technology support for end-users (rehabilitation professionals and patients)
are necessary for routine implementation into clinical practice [122]. Moving a system from laboratory
development into commercial production therefore becomes an important goal for system developers.
System developers and their manufacturing partners will need to ensure that any systems sold as
medical- (or research-grade) devices will need to meet the clinical safety standards defined by the
International Organization of Standards (ISO/TC 173 for Assistive Products and ISO 10667-1:2011
for Assessment Service Delivery) and evaluated by national or multi-national regulatory agencies.
Ideally, a system would be marketable to both clinicians and direct to consumers, as that would
facilitate uptake [59,123]. While it is possible that research-grade device systems that are compliant
with clinical regulatory standards can be adopted into clinical care, systems that are sold directly to
patients and other consumers will better enable the wide-spread, ubiquitous adoption that would
be most desirable. Time benchmarks flow from the previously discussed need to maximize patient
care time and minimize undue burden for busy clinicians (Figures 1 and 2). While many, varying
protocols for wearing duration may be used going forward, a device that can be comfortably worn
for 12–24 h at time would be an excellent staring point and would facilitate adherence to wearing.
A device system that works as intended/programmed for every patient is a prerequisite for wide-spread
clinical adoption [59]. If devices are fickle and do not work (i.e. fail to record, store, or upload data)
even a small percentage of the time, rehabilitation clinicians and patients will become frustrated and
discontinue use. The most challenging and time-consuming benchmarks to achieve will be accurate
algorithms and standardization of variables of interest that are reliable, valid, and responsive in
the heterogeneous physical rehabilitation clinic populations. Since clinicians typically carry patient
caseloads that include more than one patient population (e.g., Monday morning caseload includes a
person with stroke, a person with multiple sclerosis, and a person with Parkinson disease), algorithms
that work across populations and the ability to select specific variables of interest will make it easier to
implement a wearable device system into daily practice. Finally, consumer-friendly reports that are
quickly understandable to clinicians, patients, and families and integrated into the electronic medical
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record will allow the movement performance data collected from daily life to be used for shared clinical
decision making and motivation.
4.2. Example Application of Benchmarks to A Currently-Available System
This section applies the benchmarks to a currently-available wearable device system as an
example. The example system is the Actigraph wGT3X-BT device paired with the ActiLife software
(Actigraph Inc, Pensacola, FL, USA). This system is one of the most commonly used in North America.
Figure 4 is a picture of the wearable devices on a participant (Figure 4A) and a screen-shot of the
software interface (Figure 4B). The wGT3X-BT contains a solid state, triaxial, microelectromechanical
system (MEMS) accelerometer, an ambient light sensor, and a capacitive proximity sensor to detect
wear time. It measures 4.6 × 3.3 × 1.5 cm and weighs 19 g.
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Figure 4. (A): Photo of a participant wearing the Actigraph wGT3X-BT devices on each wrist.
(B): A screen shot of the ActiLife software interface used to interact with the wearable device.
The software provides options to change various recording parameters (start and stop times, sampling
rate, etc.) prior to recording/collecting data.
Sampling rates can be set within a 30–100 Hz range, with slower sampling rates enabling longer
data collection periods. The accelerometer has a dynamic range of +/− 8 g. Memory is 4 GB, with a
battery life of 25 days and data storage possible for up to 180 days. The device has Bluetooth
communication capability, which when activated, reduces battery life.
We benchmark this wearable device system’s use for capturing upper limb performance in daily life,
indexed by the use ratio variable in Table 3. As briefly mentioned in the previous section, the use ratio
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is a variable quantifying the relative duration of movement in one limb to the other. Determination of
benchmark achievement was decided based on ours and others experience with the wearable device
system (convenience, time, ease, comfort, device operations, and reporting benchmarks) and the
references included in the prior section (algorithm and standardization benchmarks).
Table 3. Application of benchmarks to a current wearable device system, the Actigraph wGT3X-BT and
ActiLife software for measuring upper limb performance in daily life, indexed by the use ratio variable.
Progress toward Benchmark
Convenience for purchase and use
Commercial-availability achieved. Can be easily purchased.
Consumer-grade not achieved. Marketed and sold as research-grade device.
Technology support helpful for researchers but would be too difficult for
clinician or patient consumers.
Initial set-up time for clinician Not achieved. Current time estimate is 18 min.
Routine set-up time for clinician Not achieved. Current time estimate is 8–10 min.
Time to extract data and generate output or report Not achieved. Current time estimate, using ActiLife + custom-writtensoftware in MATLAB or R is 15 min
Ease of donning/doffing for patient Achieved. Can be done at home for most patients without assistancefrom another person.
Comfort for extended wear
Achieved. Allows for variety of strapping options and has been worn
12–24 h by hundreds of patients, with many wearing it for 24 hrs 1x/wk
or 1x/month. Water resistant.
Device operations Achieved. Have lost data <2% of the time.
Algorithms for extracting data and generating
variables of interest
Achieved for use ratio. Algorithm is stable across a range of movement
abilities in typical adults and children, and persons with stroke.
Standardization of variable of interest: Use ratio
Reliability achieved. Test-retest reliability coefficient = 0.86 [79]
Validity achieved for adult stroke population, but not other populations [99].
Captures relative use of the upper limbs, which is stable and narrowly
distributed in referent populations [83,88], but wide-ranging post stroke.
Responsive to change achieved. Can detect changes of ≤5% [32,79].
Clinical relevance of change not achieved. Currently unknown how much
change is clinically meaningful.
Sensor-independent units achieved. Values are a ratio, making differences
across sensors irrelevant.
Report to clinician and patient
Not achieved. Current output can be consumed by trained researchers
but is not clinician-, patient-, or family friendly. Output is not integrated
with electronic medical record.
As can be seen in the right column of Table 3, around half of the proposed benchmarks have been
achieved to date for this wearable device system and variable of interest. We respectfully note that this
system is targeted for researchers and not for rehabilitation clinicians and patients. The conclusion
drawn from Table 3 is that this wearable device system and its corresponding variable of interest does
not yet meet all the benchmarks proposed here for widespread implementation into routine clinical
rehabilitation practice. This variable of interest first appeared in published literature in the year 2000.
Similarly, the wearable device system has been commercially available for more than 10 years and is
the device system that is most commonly used in rehabilitation research studies. Thus, even a system
that is commonly used by researchers is not yet ready for clinicians and patients.
Many new commercially- and laboratory-available wearable device systems are introduced each
year. We are unable to benchmark a newer device system for this review because new systems,
by default, have limited publications about how they operate and the variables that are derived from
them. Publications from commercial entities are often not available at all, or come in the form of
white papers that are not peer-reviewed. Publications from research laboratories about brand new
device systems often report information about the device system and testing in a few healthy, young
participants and/or a few patients, but do not yet have sufficient information/detail for assessing
progress towards achievement of the proposed benchmarks for adoption into clinical care. As can be
seen in this benchmarking exercise, it takes a long time for new devices to be picked up by the clinical
research community and the generation of subsequent publications documenting clinical feasibility
Sensors 2020, 20, 5744 15 of 21
and standardization of variables. Nonetheless, the benchmarking exercise serves as a useful example
of the collective progress that needs occur.
5. Conclusions
In the foreseeable future, the promise of wearable sensor technology for improving physical
rehabilitation practice will be realized (Figure 3). A key goal for the field is to work to move
wearable device systems that measure human movement into routine clinical practice. Major barriers
to implementation arise from both current clinical practice and from the wearable device systems
themselves. Clinical practice barriers include the busy clinical environment and a not-yet full realization
of the value of the critical information that can be obtained. Wearable device system barriers include:
(1) consumer-grade devices that are not accurate for many physical rehabilitation patient populations;
(2) research-grade devices that are not user-friendly for clinicians or patients; (3) insufficient published
data regarding reliability, validity, and responsiveness of output variables that can inform clinical
decisions; and (4) the need to have these data on a range of output variables so that clinicians can select
the most appropriate ones for specific patients.
As noted in the Introduction, we are at the beginning of this effort. Next generation wearable
sensors and device systems will be smaller, faster, and allow enormous flexibility for clinicians
and patients to gather data via wireless sensors networks and secure cloud technology, facilitating
widespread adoption. Comparing the current status of the field to the development of telephones
through smart phones, we are entering the early 1900s, when telephones were present and available
in select locations, and switchboard operators were required to make connections between parties.
Similarly, wearable devices systems have become increasing common in the research-world and require
research-trained personnel to make them work. The collective efforts of engineers, computer scientists,
clinician-scientists, and clinicians can push us all towards a future with sleek, ubiquitous, and easy to
use wearable device systems in physical rehabilitation practice.
Author Contributions: All authors participated in conceptualization, writing, editing, reviewing, and approving
this paper. All authors have read and agreed to the published version of the manuscript.
Funding: This work was funded by NIH R01HD068290.
Acknowledgments: We thank our current and former lab members and all of the research participants who have
contributed to our understanding of how, when, and why to deploy wearable sensor systems for rehabilitation
research and clinical practice.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
References
1. WHO. Towards A Common Language for Functioning, Disability, and Health: ICF; World Health Organization:
Geneva, Switzerland, 2002.
2. Dobkin, B.H.; Martinez, C. Wearable Sensors to Monitor, Enable Feedback, and Measure Outcomes of
Activity and Practice. Curr. Neurol. Neurosci. Rep. 2018, 18, 87. [CrossRef] [PubMed]
3. Louie, D.R.; Bird, M.L.; Menon, C.; Eng, J.J. Perspectives on the prospective development of stroke-specific
lower extremity wearable monitoring technology: A qualitative focus group study with physical therapists
and individuals with stroke. J. Neuroeng. Rehabil. 2020, 17, 31. [CrossRef] [PubMed]
4. Hayhurst, C. Measuring by Value Not Volume. Available online: https://www.apta.org/apta-magazine/2015/
07/01/measuring-by-value-not-volume (accessed on 15 July 2020).
5. Host, H.H.; Lang, C.E.; Hildebrand, M.W.; Zou, D.; Binder, E.F.; Baum, C.M.; Freedland, K.E.; Morrow-Howell, N.;
Lenze, E.J. Patient Active Time During Therapy Sessions in Postacute Rehabilitation: Development and Validation
of a New Measure. Phys. Occup. Ther. Geriatr. 2014, 32, 169–178. [CrossRef] [PubMed]
Sensors 2020, 20, 5744 16 of 21
6. Talkowski, J.B.; Lenze, E.J.; Munin, M.C.; Harrison, C.; Brach, J.S. Patient participation and physical activity
during rehabilitation and future functional outcomes in patients after hip fracture. Arch. Phys. Med. Rehabil.
2009, 90, 618–622. [CrossRef] [PubMed]
7. Bayley, M.T.; Hurdowar, A.; Richards, C.L.; Korner-Bitensky, N.; Wood-Dauphinee, S.; Eng, J.J.; McKay-Lyons, M.;
Harrison, E.; Teasell, R.; Harrison, M.; et al. Barriers to implementation of stroke rehabilitation evidence:
Findings from a multi-site pilot project. Disabil. Rehabil. 2012, 34, 1633–1638. [CrossRef] [PubMed]
8. Noonan, V.K.; Moore, J.L. Knowledge Translation: The Catalyst for Innovation of Neurologic Physical
Therapy. J. Neurol. Phys. Ther. 2016, 40, 67–70. [CrossRef]
9. Wright, S.P.; Hall Brown, T.S.; Collier, S.R.; Sandberg, K. How consumer physical activity monitors could
transform human physiology research. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2017, 312, R358–R367.
[CrossRef]
10. Standards of Practice for Physical Therapy. Available online: https://www.apta.org/apta-and-you/leadership-
and-governance/policies/standards-of-practice-pt (accessed on 15 July 2020).
11. Blau, R.; Bolus, S.; Carolan, T.; Kramer, D.; Mahoney, E.; Jette, D.U.; Beal, J.A. The experience of providing
physical therapy in a changing health care environment. Phys. Ther. 2002, 82, 648–657. [CrossRef]
12. Lang, C.E.; Waddell, K.J.; Klaesner, J.W.; Bland, M.D. A Method for Quantifying Upper Limb Performance in
Daily Life Using Accelerometers. J. Vis. Exp. 2017, 122, 55673. [CrossRef]
13. Physical Therapy Outcomes Registry. Available online: http://www.ptoutcomes.com/home.aspx (accessed
on 4 September 2020).
14. Moore, J.L.; Potter, K.; Blankshain, K.; Kaplan, S.L.; O’Dwyer, L.C.; Sullivan, J.E. A Core Set of Outcome
Measures for Adults with Neurologic Conditions Undergoing Rehabilitation: A CLINICAL PRACTICE
GUIDELINE. J. Neurol. Phys. Ther. 2018, 42, 174–220. [CrossRef]
15. Waddell, K.J.; Birkenmeier, R.L.; Bland, M.D.; Lang, C.E. An exploratory analysis of the self-reported goals
of individuals with chronic upper-extremity paresis following stroke. Disabil. Rehabil. 2016, 38, 853–857.
[CrossRef] [PubMed]
16. Danks, K.A.; Pohlig, R.T.; Roos, M.; Wright, T.R.; Reisman, D.S. Relationship Between Walking Capacity,
Biopsychosocial Factors, Self-efficacy, and Walking Activity in Persons Poststroke. J. Neurol. Phys. Ther. 2016,
40, 232–238. [CrossRef] [PubMed]
17. Thilarajah, S.; Mentiplay, B.F.; Bower, K.J.; Tan, D.; Pua, Y.H.; Williams, G.; Koh, G.; Clark, R.A. Factors
Associated with Post-Stroke Physical Activity: A Systematic Review and Meta-Analysis. Arch. Phys. Med.
Rehabil. 2018, 99, 1876–1889. [CrossRef] [PubMed]
18. Holleran, C.L.; Bland, M.D.; Reisman, D.S.; Ellis, T.D.; Earhart, G.M.; Lang, C.E. Day-to-Day Variability of
Walking Performance Measures in Individuals Poststroke and Individuals with Parkinson Disease. J. Neurol.
Phys. Ther. 2020, 44, 241–247. [CrossRef] [PubMed]
19. Prince, S.A.; Adamo, K.B.; Hamel, M.E.; Hardt, J.; Connor Gorber, S.; Tremblay, M. A comparison of direct
versus self-report measures for assessing physical activity in adults: A systematic review. Int. J. Behav. Nutr.
Phys. Act. 2008, 5, 56. [CrossRef] [PubMed]
20. Waddell, K.J.; Lang, C.E. Comparison of Self-Report Versus Sensor-Based Methods for Measuring the Amount
of Upper Limb Activity Outside the Clinic. Arch. Phys. Med. Rehabil. 2018, 99, 1913–1916. [CrossRef]
21. Rand, D.; Eng, J.J. Disparity between functional recovery and daily use of the upper and lower extremities
during subacute stroke rehabilitation. Neurorehabil. Neural. Repair. 2012, 26, 76–84. [CrossRef]
22. Doman, C.A.; Waddell, K.J.; Bailey, R.R.; Moore, J.L.; Lang, C.E. Changes in Upper-Extremity Functional
Capacity and Daily Performance During Outpatient Occupational Therapy for People with Stroke. Am. J.
Occup. Ther. 2016, 70, 7003290040p1–7003290040p11. [CrossRef]
23. Waddell, K.J.; Strube, M.J.; Bailey, R.R.; Klaesner, J.W.; Birkenmeier, R.L.; Dromerick, A.W.; Lang, C.E. Does
Task-Specific Training Improve Upper Limb Performance in Daily Life Poststroke? Neurorehabil. Neural.
Repair. 2017, 31, 290–300. [CrossRef]
24. Ardestani, M.M.; Henderson, C.E.; Hornby, T.G. Improved walking function in laboratory does not guarantee
increased community walking in stroke survivors: Potential role of gait biomechanics. J. Biomech. 2019, 91,
151–159. [CrossRef]
25. Benson, L.C.; Clermont, C.A.; Bosnjak, E.; Ferber, R. The use of wearable devices for walking and running
gait analysis outside of the lab: A systematic review. Gait Posture 2018, 63, 124–138. [CrossRef]
Sensors 2020, 20, 5744 17 of 21
26. Braito, I.; Maselli, M.; Sgandurra, G.; Inguaggiato, E.; Beani, E.; Cecchi, F.; Cioni, G.; Boyd, R. Assessment of
upper limb use in children with typical development and neurodevelopmental disorders by inertial sensors:
A systematic review. J. Neuroeng. Rehabil. 2018, 15, 94. [CrossRef] [PubMed]
27. Brickwood, K.J.; Watson, G.; O’Brien, J.; Williams, A.D. Consumer-Based Wearable Activity Trackers Increase
Physical Activity Participation: Systematic Review and Meta-Analysis. JMIR Mhealth Uhealth 2019, 7, e11819.
[CrossRef] [PubMed]
28. Danks, K.A.; Pohlig, R.; Reisman, D.S. Combining Fast-Walking Training and a Step Activity Monitoring
Program to Improve Daily Walking Activity After Stroke: A Preliminary Study. Arch. Phys. Med. Rehabil.
2016, 97 (Suppl. 9), S185–S193. [CrossRef]
29. Dobkin, B.H.; Dorsch, A. The promise of mHealth: Daily activity monitoring and outcome assessments by
wearable sensors. Neurorehabil. Neural. Repair. 2011, 25, 788–798. [CrossRef] [PubMed]
30. Danks, K.A.; Roos, M.A.; McCoy, D.; Reisman, D.S. A step activity monitoring program improves real world
walking activity post stroke. Disabil. Rehabil. 2014, 36, 2233–2236. [CrossRef]
31. Moore, J.L.; Roth, E.J.; Killian, C.; Hornby, T.G. Locomotor training improves daily stepping activity and
gait efficiency in individuals poststroke who have reached a “plateau” in recovery. Stroke 2010, 41, 129–135.
[CrossRef]
32. Urbin, M.A.; Waddell, K.J.; Lang, C.E. Acceleration Metrics Are Responsive to Change in Upper Extremity
Function of Stroke Survivors. Arch. Phys. Med. Rehabil. 2015, 96, 854–861. [CrossRef]
33. Moore, S.A.; Hallsworth, K.; Plotz, T.; Ford, G.A.; Rochester, L.; Trenell, M.I. Physical activity, sedentary
behaviour and metabolic control following stroke: A cross-sectional and longitudinal study. PLoS ONE 2013,
8, e55263. [CrossRef]
34. Cavanaugh, J.T.; Ellis, T.D.; Earhart, G.M.; Ford, M.P.; Foreman, K.B.; Dibble, L.E. Capturing ambulatory
activity decline in Parkinson’s disease. J. Neurol. Phys. Ther. 2012, 36, 51–57. [CrossRef]
35. Goldsack, J.C.; Coravos, A.; Bakker, J.P.; Bent, B.; Dowling, A.V.; Fitzer-Attas, C.; Godfrey, A.; Godino, J.G.;
Gujar, N.; Izmailova, E.; et al. Verification, analytical validation, and clinical validation (V3): The foundation
of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs). NPJ Digit. Med. 2020, 3, 55.
[CrossRef] [PubMed]
36. Evenson, K.R.; Goto, M.M.; Furberg, R.D. Systematic review of the validity and reliability of
consumer-wearable activity trackers. Int. J. Behav. Nutr. Phys. Act. 2015, 12, 159. [CrossRef] [PubMed]
37. Fokkema, T.; Kooiman, T.J.; Krijnen, W.P.; Van der Schans, C.P.; De Groot, M. Reliability and Validity of Ten
Consumer Activity Trackers Depend on Walking Speed. Med. Sci. Sports Exerc. 2017, 49, 793–800. [CrossRef]
[PubMed]
38. Tophoj, K.H.; Petersen, M.G.; Saebye, C.; Baad-Hansen, T.; Wagner, S. Validity and Reliability Evaluation
of Four Commercial Activity Trackers’ Step Counting Performance. Telemed. J. E Health 2018, 24, 669–677.
[CrossRef] [PubMed]
39. Duclos, N.C.; Aguiar, L.T.; Aissaoui, R.; Faria, C.; Nadeau, S.; Duclos, C. Activity Monitor Placed at
the Nonparetic Ankle Is Accurate in Measuring Step Counts During Community Walking in Poststroke
Individuals: A Validation Study. PM R 2019, 11, 963–971. [CrossRef]
40. Macko, R.F.; Haeuber, E.; Shaughnessy, M.; Coleman, K.L.; Boone, D.A.; Smith, G.V.; Silver, K.H.
Microprocessor-based ambulatory activity monitoring in stroke patients. Med. Sci. Sports Exerc. 2002, 34,
394–399. [CrossRef]
41. Fulk, G.D.; Combs, S.A.; Danks, K.A.; Nirider, C.D.; Raja, B.; Reisman, D.S. Accuracy of 2 activity monitors
in detecting steps in people with stroke and traumatic brain injury. Phys. Ther. 2014, 94, 222–229. [CrossRef]
42. Tedesco, S.; Sica, M.; Ancillao, A.; Timmons, S.; Barton, J.; O’Flynn, B. Accuracy of consumer-level and
research-grade activity trackers in ambulatory settings in older adults. PLoS ONE 2019, 14, e0216891. [CrossRef]
43. Feehan, L.M.; Geldman, J.; Sayre, E.C.; Park, C.; Ezzat, A.M.; Yoo, J.Y.; Hamilton, C.B.; Li, L.C. Accuracy of
Fitbit Devices: Systematic Review and Narrative Syntheses of Quantitative Data. JMIR Mhealth Uhealth 2018,
6, e10527. [CrossRef]
44. Larsen, R.T.; Korfitsen, C.B.; Juhl, C.B.; Andersen, H.B.; Langberg, H.; Christensen, J. Criterion validity for
step counting in four consumer-grade physical activity monitors among older adults with and without
rollators. Eur. Rev. Aging Phys. Act. 2020, 17, 1. [CrossRef]
45. Rozanski, G.M.; Aqui, A.; Sivakumaran, S.; Mansfield, A. Consumer Wearable Devices for Activity Monitoring
Among Individuals After a Stroke: A Prospective Comparison. JMIR Cardio 2018, 2, e1. [CrossRef] [PubMed]
Sensors 2020, 20, 5744 18 of 21
46. Clarke, C.L.; Taylor, J.; Crighton, L.J.; Goodbrand, J.A.; McMurdo, M.E.T.; Witham, M.D. Validation of the
AX3 triaxial accelerometer in older functionally impaired people. Aging Clin. Exp. Res. 2017, 29, 451–457.
[CrossRef] [PubMed]
47. Wendel, N.; Macpherson, C.E.; Webber, K.; Hendron, K.; DeAngelis, T.; Colon-Semenza, C.; Ellis, T. Accuracy
of Activity Trackers in Parkinson Disease: Should We Prescribe Them? Phys. Ther. 2018, 98, 705–714. [CrossRef]
[PubMed]
48. Maganja, S.A.; Clarke, D.C.; Lear, S.A.; Mackey, D.C. Formative Evaluation of Consumer-Grade Activity
Monitors Worn by Older Adults: Test-Retest Reliability and Criterion Validity of Step Counts. JMIR Form.
Res. 2020, 4, e16537. [CrossRef] [PubMed]
49. Sandroff, B.M.; Motl, R.W.; Pilutti, L.A.; Learmonth, Y.C.; Ensari, I.; Dlugonski, D.; Klaren, R.E.; Balantrapu, S.;
Riskin, B.J. Accuracy of StepWatch and ActiGraph accelerometers for measuring steps taken among persons
with multiple sclerosis. PLoS ONE 2014, 9, e93511. [CrossRef] [PubMed]
50. Wendland, D.M.; Sprigle, S.H. Activity monitor accuracy in persons using canes. J. Rehabil. Res. Dev. 2012,
49, 1261–1268. [CrossRef] [PubMed]
51. Mudge, S.; Stott, N.S. Test–retest reliability of the StepWatch Activity Monitor outputs in individuals with
chronic stroke. Clin. Rehabil. 2008, 22, 871–877. [CrossRef]
52. Bowden, M.G.; Behrman, A.L. Step Activity Monitor: Accuracy and test-retest reliability in persons with
incomplete spinal cord injury. J. Rehabil. Res. Dev. 2007, 44, 355–362. [CrossRef]
53. Haeuber, E.; Shaughnessy, M.; Forrester, L.W.; Coleman, K.L.; Macko, R.F. Accelerometer monitoring of
home- and community-based ambulatory activity after stroke. Arch. Phys. Med. Rehabil. 2004, 85, 1997–2001.
[CrossRef]
54. Schmidt, A.L.; Pennypacker, M.L.; Thrush, A.H.; Leiper, C.I.; Craik, R.L. Validity of the StepWatch Step
Activity Monitor: Preliminary findings for use in persons with Parkinson disease and multiple sclerosis.
J. Geriatr. Phys. Ther. 2011, 34, 41–45. [CrossRef]
55. Rand, D.; Eng, J.J.; Tang, P.F.; Jeng, J.S.; Hung, C. How active are people with stroke? Use of accelerometers
to assess physical activity. Stroke 2009, 40, 163–168. [CrossRef] [PubMed]
56. Paul, S.S.; Ellis, T.D.; Dibble, L.E.; Earhart, G.M.; Ford, M.P.; Foreman, K.B.; Cavanaugh, J.T. Obtaining Reliable
Estimates of Ambulatory Physical Activity in People with Parkinson’s Disease. J. Parkinsons. Dis. 2016, 6,
301–305. [CrossRef] [PubMed]
57. Dorsch, A.K.; Thomas, S.; Xu, X.; Kaiser, W.; Dobkin, B.H.; Investigators, S. SIRRACT: An International
Randomized Clinical Trial of Activity Feedback During Inpatient Stroke Rehabilitation Enabled by Wireless
Sensing. Neurorehabil. Neural. Repair. 2015, 29, 407–415. [CrossRef] [PubMed]
58. Appelboom, G.; Yang, A.H.; Christophe, B.R.; Bruce, E.M.; Slomian, J.; Bruyere, O.; Bruce, S.S.; Zacharia, B.E.;
Reginster, J.Y.; Connolly, E.S., Jr. The promise of wearable activity sensors to define patient recovery.
J. Clin. Neurosci. 2014, 21, 1089–1093. [CrossRef] [PubMed]
59. Morris, J.; Jones, M.; Thompson, N.; Wallace, T.; DeRuyter, F. Clinician Perspectives on mRehab Interventions
and Technologies for People with Disabilities in the United States: A National Survey. Int. J. Environ. Res.
Public Health 2019, 16, 4220. [CrossRef] [PubMed]
60. Jerosch-Herold, C. An evidenced-based approach to choosing outcome measures: A checklist for the critical
appraisal of validity, reliability, and responsiveness studies. Brit. J. Occup. Ther. 2005, 68, 347–353. [CrossRef]
61. Mokkink, L.B.; Terwee, C.B.; Patrick, D.L.; Alonso, J.; Stratford, P.W.; Knol, D.L.; Bouter, L.M.; de Vet, H.C.
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement
properties for health-related patient-reported outcomes. J. Clin. Epidemiol. 2010, 63, 737–745. [CrossRef]
62. Portney, L.G.; Watkins, M.P. Foundations of Clinical Research: Applications to Clinical Practice, 1st ed.; Appleton &
Lange: Norwalk, CT, USA, 1993; p. 722.
63. Guidance for Industry: Patient-Reported Outcome Measures Use in Medical Product Development to Support Labeling
Claims; Center for Biologics Evaluation and Research: Washington DC, USA, 2009.
64. Cavanaugh, J.T.; Ellis, T.D.; Earhart, G.M.; Ford, M.P.; Foreman, K.B.; Dibble, L.E. Toward Understanding
Ambulatory Activity Decline in Parkinson Disease. Phys. Ther. 2015, 95, 1142–1150. [CrossRef]
65. Roos, M.A.; Rudolph, K.S.; Reisman, D.S. The structure of walking activity in people after stroke compared
with older adults without disability: A cross-sectional study. Phys. Ther. 2012, 92, 1141–1147. [CrossRef]
66. Orendurff, M.S.; Schoen, J.A.; Bernatz, G.C.; Segal, A.D.; Klute, G.K. How humans walk: Bout duration,
steps per bout, and rest duration. J. Rehabil. Res. Dev. 2008, 45, 1077–1089. [CrossRef]
Sensors 2020, 20, 5744 19 of 21
67. Fulk, G.D.; Reynolds, C.; Mondal, S.; Deutsch, J.E. Predicting home and community walking activity in
people with stroke. Arch. Phys. Med. Rehabil. 2010, 91, 1582–1586. [CrossRef]
68. Mudge, S.; Stott, N.S.; Walt, S.E. Criterion validity of the StepWatch Activity Monitor as a measure of walking
activity in patients after stroke. Arch. Phys. Med. Rehabil. 2007, 88, 1710–1715. [CrossRef]
69. Jarchi, D.; Pope, J.; Lee, T.K.M.; Tamjidi, L.; Mirzaei, A.; Sanei, S. A Review on Accelerometry-Based Gait
Analysis and Emerging Clinical Applications. IEEE Rev. Biomed. Eng. 2018, 11, 177–194. [CrossRef]
70. Bregou Bourgeois, A.; Mariani, B.; Aminian, K.; Zambelli, P.Y.; Newman, C.J. Spatio-temporal gait analysis in
children with cerebral palsy using, foot-worn inertial sensors. Gait Posture 2014, 39, 436–442. [CrossRef]
[PubMed]
71. Chadwell, A.; Kenney, L.; Granat, M.; Thies, S.; Head, J.S.; Galpin, A. Visualisation of upper limb activity
using spirals: A new approach to the assessment of daily prosthesis usage. Prosthet. Orthot. Int. 2018, 42,
37–44. [CrossRef] [PubMed]
72. Chadwell, A.; Kenney, L.; Granat, M.H.; Thies, S.; Head, J.; Galpin, A.; Baker, R.; Kulkarni, J. Upper limb
activity in myoelectric prosthesis users is biased towards the intact limb and appears unrelated to goal-directed
task performance. Sci. Rep. 2018, 8, 11084. [CrossRef]
73. Gebruers, N.; Vanroy, C.; Truijen, S.; Engelborghs, S.; De Deyn, P.P. Monitoring of physical activity after
stroke: A systematic review of accelerometry-based measures. Arch. Phys. Med. Rehabil. 2010, 91, 288–297.
[CrossRef]
74. Trujillo-Priego, I.A.; Lane, C.J.; Vanderbilt, D.L.; Deng, W.; Loeb, G.E.; Shida, J.; Smith, B.A. Development of
a Wearable Sensor Algorithm to Detect the Quantity and Kinematic Characteristics of Infant Arm Movement
Bouts Produced across a Full Day in the Natural Environment. Technologies 2017, 5, 39. [CrossRef]
75. de Lucena, D.S.; Stoller, O.; Rowe, J.B.; Chan, V.; Reinkensmeyer, D.J. Wearable sensing for rehabilitation
after stroke: Bimanual jerk asymmetry encodes unique information about the variability of upper extremity
recovery. IEEE Int. Conf. Rehabil. Robot. 2017, 2017, 1603–1608.
76. Urbin, M.A.; Bailey, R.R.; Lang, C.E. Validity of body-worn sensor acceleration metrics to index upper
extremity function in hemiparetic stroke. J. Neurol. Phys. Ther. 2015, 39, 111–118. [CrossRef]
77. Urbin, M.A.; Hong, X.; Lang, C.E.; Carter, A.R. Resting-State Functional Connectivity and Its Association
with Multiple Domains of Upper-Extremity Function in Chronic Stroke. Neurorehabil. Neural. Repair. 2014,
28, 761–769. [CrossRef] [PubMed]
78. van der Pas, S.C.; Verbunt, J.A.; Breukelaar, D.E.; van Woerden, R.; Seelen, H.A. Assessment of arm activity
using triaxial accelerometry in patients with a stroke. Arch. Phys. Med. Rehabil. 2011, 92, 1437–1442. [CrossRef]
[PubMed]
79. Uswatte, G.; Foo, W.L.; Olmstead, H.; Lopez, K.; Holand, A.; Simms, L.B. Ambulatory monitoring of arm
movement using accelerometry: An objective measure of upper-extremity rehabilitation in persons with
chronic stroke. Arch. Phys. Med. Rehabil. 2005, 86, 1498–1501. [CrossRef] [PubMed]
80. Uswatte, G.; Giuliani, C.; Winstein, C.; Zeringue, A.; Hobbs, L.; Wolf, S.L. Validity of accelerometry for monitoring
real-world arm activity in patients with subacute stroke: Evidence from the extremity constraint-induced
therapy evaluation trial. Arch. Phys. Med. Rehabil. 2006, 87, 1340–1345. [CrossRef] [PubMed]
81. Uswatte, G.; Miltner, W.H.; Foo, B.; Varma, M.; Moran, S.; Taub, E. Objective measurement of functional
upper-extremity movement using accelerometer recordings transformed with a threshold filter. Stroke 2000,
31, 662–667. [CrossRef]
82. Hoyt, C.R.; Brown, S.K.; Sherman, S.K.; Wood-Smith, M.; Van, A.N.; Ortega, M.; Nguyen, A.L.; Lang, C.E.;
Schlaggar, B.L.; Dosenbach, N.U.F. Using accelerometry for measurement of motor behavior in children:
Relationship of real-world movement to standardized evaluation. Res. Dev. Disabil. 2020, 96, 103546.
[CrossRef]
83. Hoyt, C.R.; Van, A.N.; Ortega, M.; Koller, J.M.; Everett, E.A.; Nguyen, A.L.; Lang, C.E.; Schlaggar, B.L.;
Dosenbach, N.U.F. Detection of Pediatric Upper Extremity Motor Activity and Deficits with Accelerometry.
JAMA Netw. Open 2019, 2, e192970. [CrossRef]
84. Bailey, R.R. Assessment of Real-World Upper Limb Activity in Adults with Chronic Stroke; Washington University:
St. Louis, MO, USA, 2015.
85. Bailey, R.R.; Birkenmeier, R.L.; Lang, C.E. Real-world affected upper limb activity in chronic stroke: An
examination of potential modifying factors. Top. Stroke Rehabil. 2015, 22, 26–33. [CrossRef]
Sensors 2020, 20, 5744 20 of 21
86. Bailey, R.R.; Klaesner, J.W.; Lang, C.E. An accelerometry-based methodology for assessment of real-world
bilateral upper extremity activity. PLoS ONE 2014, 9, e103135. [CrossRef]
87. Bailey, R.R.; Klaesner, J.W.; Lang, C.E. Quantifying Real-World Upper-Limb Activity in Nondisabled Adults
and Adults with Chronic Stroke. Neurorehabilit. Neural Repair 2015, 29, 969–978. [CrossRef]
88. Bailey, R.R.; Lang, C.E. Upper-limb activity in adults: Referent values using accelerometry. J. Rehabil. Res.
Dev. 2013, 50, 1213–1222. [CrossRef] [PubMed]
89. Lemmens, R.J.; Timmermans, A.A.; Janssen-Potten, Y.J.; Pulles, S.A.; Geers, R.P.; Bakx, W.G.; Smeets, R.J.;
Seelen, H.A. Accelerometry measuring the outcome of robot-supported upper limb training in chronic stroke:
A randomized controlled trial. PLoS ONE 2014, 9, e96414. [CrossRef] [PubMed]
90. Lang, C.E.; Wagner, J.M.; Edwards, D.F.; Dromerick, A.W. Upper Extremity Use in People with Hemiparesis
in the First Few Weeks After Stroke. J. Neurol. Phys. Ther. 2007, 31, 56–63. [CrossRef]
91. Lang, C.E.; Edwards, D.F.; Birkenmeier, R.L.; Dromerick, A.W. Estimating minimal clinically important
differences of upper-extremity measures early after stroke. Arch. Phys. Med. Rehabil. 2008, 89, 1693–1700.
[CrossRef] [PubMed]
92. Sokal, B.; Uswatte, G.; Vogtle, L.; Byrom, E.; Barman, J. Everyday movement and use of the arms: Relationship
in children with hemiparesis differs from adults. J. Pediatr. Rehabil. Med. 2015, 8, 197–206. [CrossRef]
93. Seitz, R.J.; Hildebold, T.; Simeria, K. Spontaneous arm movement activity assessed by accelerometry is a
marker for early recovery after stroke. J. Neurol. 2011, 258, 457–463. [CrossRef]
94. Balasubramanian, S.; Melendez-Calderon, A.; Burdet, E. A robust and sensitive metric for quantifying
movement smoothness. IEEE Trans. Biomed. Eng. 2012, 59, 2126–2136. [CrossRef] [PubMed]
95. Balasubramanian, S.; Melendez-Calderon, A.; Roby-Brami, A.; Burdet, E. On the analysis of movement
smoothness. J. Neuroeng. Rehabil. 2015, 12, 112. [CrossRef]
96. Thrane, G.; Emaus, N.; Askim, T.; Anke, A. Arm use in patients with subacute stroke monitored by
accelerometry: Association with motor impairment and influence on self-dependence. J. Rehabil. Med. 2011,
43, 299–304. [CrossRef]
97. Lang, C.E.; Cade, W.T. A step toward the future of seamless measurement with wearable sensors in pediatric
populations with neuromuscular diseases. Muscle Nerve 2020, 61, 265–267. [CrossRef] [PubMed]
98. van der Geest, A.; Essers, J.M.N.; Bergsma, A.; Jansen, M.; de Groot, I.J.M. Monitoring daily physical
activity of upper extremity in young and adolescent boys with Duchenne muscular dystrophy: A pilot study.
Muscle Nerve 2020, 61, 293–300. [CrossRef]
99. Smith, B.A.; Lang, C.E. Sensor Measures of Symmetry Quantify Upper Limb Movement in the Natural
Environment Across the Lifespan. Arch. Phys. Med. Rehabil. 2019, 100, 1176–1183. [CrossRef]
100. Lang, C.E.; Bland, M.D.; Bailey, R.R.; Schaefer, S.Y.; Birkenmeier, R.L. Assessment of upper extremity
impairment, function, and activity after stroke: Foundations for clinical decision making. J. Hand. Ther. 2013,
26, 104–115. [CrossRef]
101. Loprinzi, P.D.; Cardinal, B.J. Measuring children’s physical activity and sedentary behaviors. J. Exerc. Sci. Fit.
2011, 9, 15–23. [CrossRef]
102. Rice, K.R.; Joschtel, B.; Trost, S.G. Validity of family child care providers’ proxy reports on children’s physical
activity. Child. Obes. 2013, 9, 393–398. [CrossRef]
103. Lobenius-Palmer, K.; Sjoqvist, B.; Hurtig-Wennlof, A.; Lundqvist, L.O. Accelerometer-Assessed Physical
Activity and Sedentary Time in Youth with Disabilities. Adapt. Phys. Activ. Q. 2018, 35, 1–19. [CrossRef]
104. King-Dowling, S.; Rodriguez, C.; Missiuna, C.; Timmons, B.W.; Cairney, J. Health-related Fitness in Preschool
Children with and without Motor Delays. Med. Sci. Sports Exerc. 2018, 50, 1442–1448. [CrossRef]
105. Wood, A.C.; Asherson, P.; Rijsdijk, F.; Kuntsi, J. Is overactivity a core feature in ADHD? Familial and
receiver operating characteristic curve analysis of mechanically assessed activity level. J. Am. Acad. Child.
Adolesc. Psychiatry 2009, 48, 1023–1030. [CrossRef]
106. Pan, C.Y.; Tsai, C.L.; Chu, C.H.; Sung, M.C.; Ma, W.Y.; Huang, C.Y. Objectively Measured Physical Activity
and Health-Related Physical Fitness in Secondary School-Aged Male Students with Autism Spectrum
Disorders. Phys. Ther. 2016, 96, 511–520. [CrossRef]
107. Brewis, A. Social and biological measures of hyperactivity and inattention: Are they describing similar
underlying constructs of child behavior? Soc. Biol. 2002, 49, 99–115. [CrossRef]
Sensors 2020, 20, 5744 21 of 21
108. Uebel, H.; Albrecht, B.; Kirov, R.; Heise, A.; Dopfner, M.; Freisleder, F.J.; Gerber, W.D.; Gunter, M.; Hassler, F.;
Ose, C.; et al. What can actigraphy add to the concept of labschool design in clinical trials? Curr. Pharm. Des.
2010, 16, 2434–2442. [CrossRef]
109. Lea, S.E.; Matt Alderson, R.; Patros, C.H.G.; Tarle, S.J.; Arrington, E.F.; Grant, D.M. Working Memory
and Motor Activity: A Comparison Across Attention-Deficit/Hyperactivity Disorder, Generalized Anxiety
Disorder, and Healthy Control Groups. Behav. Ther. 2018, 49, 419–434. [CrossRef]
110. Gapin, J.; Etnier, J.L. The relationship between physical activity and executive function performance in
children with attention-deficit hyperactivity disorder. J. Sport Exerc. Psychol. 2010, 32, 753–763. [CrossRef]
111. Heathers, J.A.J.; Gilchrist, K.H.; Hegarty-Craver, M.; Grego, S.; Goodwin, M.S. An analysis of stereotypical
motor movements and cardiovascular coupling in individuals on the autism spectrum. Biol. Psychol. 2019,
142, 90–99. [CrossRef]
112. Garcia-Pastor, T.; Salinero, J.J.; Theirs, C.I.; Ruiz-Vicente, D. Obesity Status and Physical Activity Level in
Children and Adults with Autism Spectrum Disorders: A Pilot Study. J. Autism. Dev. Disord. 2019, 49, 165–172.
[CrossRef]
113. Benson, S.; Bender, A.M.; Wickenheiser, H.; Naylor, A.; Clarke, M.; Samuels, C.H.; Werthner, P. Differences in
sleep patterns, sleepiness, and physical activity levels between young adults with autism spectrum disorder
and typically developing controls. Dev. Neurorehabil. 2019, 22, 164–173. [CrossRef]
114. Goldman, S.E.; Alder, M.L.; Burgess, H.J.; Corbett, B.A.; Hundley, R.; Wofford, D.; Fawkes, D.B.; Wang, L.;
Laudenslager, M.L.; Malow, B.A. Characterizing Sleep in Adolescents and Adults with Autism Spectrum
Disorders. J. Autism. Dev. Disord. 2017, 47, 1682–1695. [CrossRef]
115. Abrishami, M.S.; Nocera, L.; Mert, M.; Trujillo-Priego, I.A.; Purushotham, S.; Shahabi, C.; Smith, B.A.
Identification of Developmental Delay in Infants Using Wearable Sensors: Full-Day Leg Movement Statistical
Feature Analysis. IEEE J. Transl. Eng. Health Med. 2019, 7, 2800207. [CrossRef]
116. Heinze, F.; Hesels, K.; Breitbach-Faller, N.; Schmitz-Rode, T.; Disselhorst-Klug, C. Movement analysis by
accelerometry of newborns and infants for the early detection of movement disorders due to infantile cerebral
palsy. Med. Biol. Eng. Comput. 2010, 48, 765–772. [CrossRef]
117. Jiang, C.; Lane, C.J.; Perkins, E.; Schiesel, D.; Smith, B.A. Determining if wearable sensors affect infant leg
movement frequency. Dev. Neurorehabil. 2018, 21, 133–136. [CrossRef]
118. Zhu, Z.; Liu, T.; Li, G.; Li, T.; Inoue, Y. Wearable sensor systems for infants. Sensors 2015, 15, 3721–3749.
[CrossRef] [PubMed]
119. Kirste, T.; Hoffmeyer, A.; Koldrack, P.; Bauer, A.; Schubert, S.; Schroder, S.; Teipel, S. Detecting the effect of
Alzheimer’s disease on everyday motion behavior. J. Alzheimers. Dis. 2014, 38, 121–132. [CrossRef] [PubMed]
120. Matthews, L.; Hankey, C.; Penpraze, V.; Boyle, S.; Macmillan, S.; Miller, S.; Murray, H.; Pert, C.; Spanos, D.;
Robinson, N.; et al. Agreement of accelerometer and a physical activity questionnaire in adults with
intellectual disabilities. Prev. Med. 2011, 52, 361–364. [CrossRef] [PubMed]
121. Block, V.A.; Pitsch, E.; Tahir, P.; Cree, B.A.; Allen, D.D.; Gelfand, J.M. Remote Physical Activity Monitoring in
Neurological Disease: A Systematic Review. PLoS ONE 2016, 11, e0154335. [CrossRef] [PubMed]
122. Jacob, C.; Sanchez-Vazquez, A.; Ivory, C. Social, Organizational, and Technological Factors Impacting
Clinicians’ Adoption of Mobile Health Tools: Systematic Literature Review. JMIR Mhealth Uhealth 2020, 8,
e15935. [CrossRef] [PubMed]
123. Nussbaum, R.; Kelly, C.; Quinby, E.; Mac, A.; Parmanto, B.; Dicianno, B.E. Systematic Review of Mobile
Health Applications in Rehabilitation. Arch. Phys. Med. Rehabil. 2019, 100, 115–127. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
